Latest Morning Briefing Stories
California se enfrenta a un revés importante si Trump revoca la ley de salud
California tiene mucho que perder si el presidente electo Donald Trump y el Congreso liderado por republicanos cumplen con su promesa de campaña de revocar el Obamacare.
California’s Drug Price Initiative: Will Voters ‘Send A Signal To Washington’?
Despite heavy opposition from the pharmaceutical industry and skepticism from policy experts, many voters see Proposition 61 as a way to protest the nation’s mounting drug prices.
FDA Faults 12 Hospitals For Failing To Disclose Injuries, Deaths Linked To Medical Devices
The agency found several prominent facilities had not followed rules on reporting incidents in which patients were harmed.
California Rules About Violence Against Health Workers Could Become A Model
New workplace health rules in California would go beyond existing safety standards by requiring private health care facilities to develop specific plans to mitigate risks of violence against workers.
California’s RN Wages Now Highest In The Nation, Federal Data Show
Registered nurses in the state earn an average annual salary of $100,000, compared to a national average of $71,000.
California’s Latino Doctors Push For More Of Their Own
More than one-third of the state’s Latino physicians plan to retire within the next 10 years, according to a new survey.
New California Law Will More Finely Parse Health Data On Asians
Advocates hope better data will help ethnic communities.
Everything Californians Wanted To Know About Their Health Plan (But Were Afraid To Ask)
A new online database created by the Department of Managed Health Care can help consumers size up and compare insurance plans.
Beware Of Unapproved Stem Cell Treatments
Pricey and unproven therapies that sound too good to be true probably are.
Covered California Resolves Pregnancy Snafu
Officials at the state exchange say they have fixed their computer system to stop switching some low-income pregnant women into Medi-Cal without their approval.
UnitedHealth And University Of California To Forge Unique Alliance
The nation’s largest insurer and the state’s university health system intend to offer a health plan option to self-funded employers in California and pursue research drawing upon a huge reservoir of patient data.
Specialty Drug Costs Soar 30% For California Pension Fund
Such medications account for more than a quarter of the state agency’s $2.1 billion in pharmacy costs.
Tobacco Tax Ballot Measure Would Fund Health Care For California’s Poor — But How?
The state tax would boost the Medi-Cal budget by millions, but it’s unclear how the money will be distributed. And that’s by design.
Remember The ‘Public Option’? Insurance Commissioner Wants To Try It In California
California Insurance Commissioner Dave Jones says a publicly run health plan would bolster competition in the state. But some question whether it would lower premiums.
Veterans Courted In California’s Ballot Fight Over Curbing Drug Prices
The initiative would prohibit California state agencies from paying more for a prescription drug than what the Department of Veterans Affairs pays. Both sides are deploying veterans’ sympathetic and trusted image to win over voters.
Newly Covered By Medi-Cal, Undocumented Children Also Seek Dental Care
Some dental clinics are expanding their hours to meet demand, but can an already stressed system satisfy the needs of children who haven’t seen a dentist in years?
Tossing Unused Surgical Supplies Wastes Millions Of Dollars, Study Finds
Researchers at the University of California, San Francisco estimate that hospitals could lose nearly $1,000 per surgery by throwing away opened but unused supplies, such as gloves and sponges.
Consumer Group Questions Role of Drug Costs In California Premium Hikes
Consumers Union says Anthem Inc. and Blue Shield of California may be exploiting furor over prescription drug prices. State regulators are looking into the issue.
Behind The EpiPen Monopoly: Lobbying Muscle, Flailing Competition, Tragic Deaths
A closer look shows that industry lobbying was just one factor in EpiPen’s sales explosion.
Under a new state law, California consumers could get money back if they were charged out-of-network prices after going to a medical provider who was listed in their health plan’s network.
